The Critical Path Institute’s Transplant Therapeutics Consortium (TTC), the American Society of Transplantation (AST), and the American Society of Transplant Surgeons (ASTS) are pleased to announce the following recipients receiving the 2022 TTC Data Trailblazer Award. This award is bestowed on individuals who demonstrated a commitment to sharing anonymized patient-level data, helping with analyses, and providing oversight to support the regulatory qualification of the iBox Scoring System. The most pressing needs in the field of kidney transplant drug development can only be met through collaboration between industry, academia, nonprofits, clinicians and regulatory agencies. The 2022 TTC Data Trailblazer Award recipients are dedicated members of the transplant community and the TTC is honored to present this to award to the following:
Congratulations to:
• Dr. Olivier Aubert, Paris Transplant Group
• Dr. Gillian Divard, Paris Transplant Group
• Dr. Thomas Dumortier, Novartis
• Dr. William (Bill) E. Fitzsimmons, TTC Senior Advisor
• Dr. Ilkka Helanterä, Helsinki University Hospital
• Dr. Alexandre Loupy, Paris Transplant Group
• Dr. Roslyn (Roz) Mannon, The Transplantation Society
• Dr. Ulf Meier-Kriesche, Veloxis Pharmaceuticals, TTC Workgroup 1 Efficacy and Endpoints Co-Lead
• Dr. Kenneth (Ken) Newell, American Society of Transplantation, TTC Workgroup 1 Efficacy and Endpoints Co-Lead
• Dr. Peter Nickerson, University of Manitoba
• Dr. Marty Polinsky, Bristol Myers Squibb
• Dr. Mark Stegall, Mayo Clinic